Medical Practice

ScheBo® • M2-PK Quick™ stool test

Product information

Modern targeted preventive care by a registered doctor can not only be carried out directly, but can also be evaluated within a few minutes — using a rapid test with the novel ScheBo® • M2-PK Quick™.

Request product

Rapid test (POC) for colorectal cancer prevention for medical practice

Today's modern colorectal cancer screening is now even easier. Targeted preventive care by a registered doctor can not only be carried out directly, but can also be evaluated within a few minutes — using a rapid test with the ScheBo® • M2-PK Quick™.

Die M2-PK is a modern enzyme biomarker and has been identified as the key enzyme in polyps and intestinal tumours. The enzyme M2-PK is completely independent of the presence of blood in the stool. M2-PK is specific for the altered metabolic activity of cells (direct procedure). Non-bleeding polyps and intestinal tumours are also detected, as the M2-PK is independent of blood.

The ScheBo® • M2-PK Quick™ stool test is a qualitative rapid test that detects the enzyme M2-PK in a highly specific manner. For proof using ScheBo® • M2-PK Quick™ In stool samples, the following applies:

Sample material: tiny stool sample

The benefits of ScheBo® • M2-PK Quick™ stool tests are:

  • high sensitivity
  • high specificity
  • independent of occult blood
  • Bleeding and non-bleeding intestinal polyps, especially those >1 cm, are recorded
  • bleeding and non-bleeding bowel tumors are discovered
  • no sensitivity to food
  • no special diet required
  • no false results due to hemorrhoids or other bleeding in the intestines
  • A single pea-sized stool sample is sufficient
  • available from the doctor

When should M2-PK be determined in stool:

  • Colorectal cancer screening

Our locations